Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Oxymetazoline for Fiberoptic Nasal Pharyngoscopy and Laryngoscopy
NCT03620513Phase 4Completed
- Sponsor
- Lumbini Medical College
- Start
- Sep 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray and Mucinex Full Force Nasal Spray, sponsored by Lumbini Medical College. Started Sep 2018; status: completed.
02
Drugs
lidocaine 10% oropharyngeal sprayMucinex Full Force Nasal Spray
Beyond the preview
Go deeper on NCT03620513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620513.